Recommended Uniform Screening Panel

The RUSP is a list of disorders that the Secretary of the Department of Health and Human Services (HHS) recommends for states to screen as part of their state universal newborn screening (NBS) programs.

Disorders on the RUSP are chosen based on evidence that supports the potential net benefit of screening, the ability of states to screen for the disorder, and the availability of effective treatments. It is recommended that every newborn be screened for all disorders on the RUSP.

Most states screen for the majority of disorders on the RUSP; newer conditions are still in process of adoption. Some states also screen for additional disorders.

Although states ultimately determine what disorders their NBS program will screen for, the RUSP establishes a standardized list of disorders that have been supported by the Advisory Committee on Heritable Disorders in Newborns and Children and recommended by the Secretary of HHS.

Conditions listed on the RUSP are part of the comprehensive preventive health guidelines supported by HRSA for infants and children under section 2713 of the Public Health Service Act. Non-grandfathered health plans are required to cover screenings included in the HRSA-supported comprehensive guidelines without charging a co-payment, co-insurance, or deductible for plan years beginning on or after the date that is one year from the Secretary’s adoption of the condition for screening.

How to Nominate a Condition

Previously Nominated Conditions (Recommended and Not Recommended for the RUSP)

Printer-Friendly Recommended Uniform Screening Panel (PDF - 67 KB)

Recommended Uniform Screening Panel¹
Core²Conditions³
(as of January 2023)
Core Condition	Metabolic Disorder			Endocrine Disorder	Hemoglobin Disorder	Other Disorder
Core Condition	Organic acid condition	Fatty acid oxidation disorders	Amino acid disorders	Endocrine Disorder	Hemoglobin Disorder	Other Disorder
3-Hydroxy-3-methyglutaric aciduria	X
3-Methylcrotonyl-CoA carboxylase deficiency	X
ß-Ketothiolase deficiency	X
Glutaric acidemia type I	X
Holocarboxylase synthase deficiency	X
Isovaleric acidemia	X
Methylmalonic acidemia (cobalamin disorders)	X
Methylmalonic acidemia (methylmalonyl-CoA mutase)	X
Propionic acidemia	X
Carnitine uptake defect/carnitine transport defect		X
Long-chain L-3 hydroxyacyl-CoA dehydrogenase deficiency		X
Medium-chain acyl-CoA dehydrogenase deficiency		X
Trifunctional protein deficiency		X
Very long-chain acyl-CoA dehydrogenase deficiency		X
Argininosuccinic aciduria			X
Citrullinemia, type I			X
Classic phenylketonuria			X
Homocystinuria			X
Maple syrup urine disease			X
Tyrosinemia, type I			X
Congenital adrenal hyperplasia				X
Primary congenital hypothyroidism				X
S, βeta-thalassemia					X
S,C disease					X
S,S disease (Sickle cell anemia)					X
Biotinidase deficiency						X
Classic galactosemia						X
Critical congenital heart disease						X
Cystic fibrosis						X
Glycogen Storage Disease Type II (Pompe)						X
Guanidinoacetate Methyltransferase Deficiency						X
Hearing loss						X
Infantile Krabbe Disease (low [GALC] galactocerebrosidase and psychosine ≥ 10nM)						X
Mucopolysaccharidosis Type I						X
Mucopolysaccharidosis Type II						X
Severe combined Immunodeficiencies						X
Spinal Muscular Atrophy due to homozygous deletion of exon 7 in SMN1						X
X-linked Adrenoleukodystrophy						X

Selection of conditions based upon “Newborn Screening: Towards a Uniform Screening Panel and System.” Genetic Med. 2006; 8(5) Suppl: S12-S252” as authored by the American College of Medical Genetics (ACMG) and commissioned by the Health Resources and Services Administration (HRSA).
Disorders that should be included in every Newborn Screening Program.
Nomenclature for Conditions based upon “Naming and Counting Disorders (Conditions) Included in Newborn Screening Panels.” Pediatrics. 2006; 117 (5) Suppl: S308-S314.

Recommended Uniform Screening Panel¹
Secondary²Conditions³
(as of January 2023)
Core Condition	Metabolic Disorder			Endocrine Disorder	Hemoglobin Disorder	Other Disorder
Core Condition	Organic acid condition	Fatty acid oxidation disorders	Amino acid disorders	Endocrine Disorder	Hemoglobin Disorder	Other Disorder
2-Methyl-3-hydroxybutyric aciduria	X
2-Methylbutyrylglycinuria	X
3-Methylglutaconic aciduria	X
Isobutyrylglycinuria	X
Malonic acidemia	X
Methylmalonic acidemia with homocystinuria	X
2,4 Dienoyl-CoA reductase deficiency		X
Carnitine acylcarnitine translocase deficiency		X
Carnitine palmitoyltransferase type I deficiency		X
Carnitine palmitoyltransferase type II deficiency		X
Glutaric acidemia type II		X
Medium/short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency		X
Medium-chain ketoacyl-CoA thiolase deficiency		X
Short-chain acyl-CoA dehydrogenase deficiency		X
Argininemia			X
Benign hyperphenylalaninemia			X
Biopterin defect in cofactor biosynthesis			X
Biopterin defect in cofactor regeneration			X
Citrullinemia, type II			X
Hypermethioninemia			X
Tyrosinemia, type II			X
Tyrosinemia, type III			X
Various other hemoglobinopathies					X
Galactoepimerase deficiency						X
Galactokinase deficiency						X
T-cell related lymphocyte deficiencies						X

Selection of conditions based upon “Newborn Screening: Towards a Uniform Screening Panel and System.” Genetic Med. 2006; 8(5) Suppl: S12-S252” as authored by the American College of Medical Genetics (ACMG) and commissioned by the Health Resources and Services Administration (HRSA).
Disorders that can be detected in the differential diagnosis of a core disorder.
Nomenclature for Conditions based upon “Naming and Counting Disorders (Conditions) Included in Newborn Screening Panels.” Pediatrics. 2006; 117 (5) Suppl: S308-S314.

Persons using assistive technology may not be able to fully access information in this file. For assistance, please email the Designated Federal Official of the ACHDNC.

Fecha de la última revisión:

July 2024

Parents: don’t struggle alone

Recommended Uniform Screening Panel